co.don AG

XTRA:CNW Stock Report

Market Cap: €6.5m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

co.don Past Earnings Performance

Past criteria checks 0/6

co.don's earnings have been declining at an average annual rate of -15.4%, while the Biotechs industry saw earnings growing at 16.9% annually. Revenues have been growing at an average rate of 10.7% per year.

Key information

-15.38%

Earnings growth rate

1.35%

EPS growth rate

Biotechs Industry Growth-14.59%
Revenue growth rate10.68%
Return on equity-214.21%
Net Margin-143.55%
Last Earnings Update30 Jun 2022

Recent past performance updates

Recent updates

Analysis Article Oct 06

Here's Why co.don (ETR:CNW) Can Afford Some Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article May 06

Health Check: How Prudently Does co.don (ETR:CNWK) Use Debt?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article Mar 15

Will co.don (ETR:CNWK) Spend Its Cash Wisely?

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Analysis Article Feb 08

Analysts Expect Breakeven For co.don AG (ETR:CNWK) Before Long

co.don AG ( ETR:CNWK ) is possibly approaching a major achievement in its business, so we would like to shine some...
Analysis Article Jan 04

co.don's(ETR:CNWK) Share Price Is Down 85% Over The Past Three Years.

While it may not be enough for some shareholders, we think it is good to see the co.don AG ( ETR:CNWK ) share price up...

Revenue & Expenses Breakdown

How co.don makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

XTRA:CNW Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2210-14110
31 Mar 2210-12110
31 Dec 2110-9110
30 Sep 218-10110
30 Jun 217-11100
31 Mar 216-13100
31 Dec 206-14100
30 Sep 206-15110
30 Jun 207-16110
31 Mar 207-14100
31 Dec 197-13100
30 Sep 196-1190
30 Jun 196-980
31 Mar 196-780
31 Dec 186-680
30 Sep 186-780
30 Jun 186-880
31 Mar 186-870
31 Dec 176-770
30 Sep 176-660
30 Jun 176-560
31 Mar 176-450
31 Dec 166-450
30 Sep 166-350
30 Jun 166-350
31 Mar 165-340
31 Dec 155-340

Quality Earnings: CNW is currently unprofitable.

Growing Profit Margin: CNW is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CNW is unprofitable, and losses have increased over the past 5 years at a rate of 15.4% per year.

Accelerating Growth: Unable to compare CNW's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CNW is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-26.8%).


Return on Equity

High ROE: CNW has a negative Return on Equity (-214.21%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/12/28 11:19
End of Day Share Price 2022/09/30 00:00
Earnings2022/06/30
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

co.don AG is covered by 3 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Peter-Thilo HaslerSphene Capital GmbH
Ulrich HuwaldWarburg Research GmbH
Harald HofWarburg Research GmbH